Oxidized MIF is a drug target at the molecular intersection between immune activation and tau cellular pathology
Mueller-Schiffmann, A., Torres, F., Kitaygorodskyy, A., Ramani, A., Alatza, A., Tschirner, S., Prikulis, I., Yu, S., Dey, D., Mallesh, S., Prasad, D., Solas, D., Bader, V., Rozemuller, A., Wray, S., Gopalakrishnan, J., Riek, R., Lingappa, V.R., Korth, C.To be published.